Human Adipose-derived Stromal Cells Accelerate Diabetic Wound Healing: Impact of Cell Formulation and Delivery

Overview

Journal Tissue Eng Part A

Specialties Anatomy & Histology
Biomedical Engineering
Biotechnology

Date 2009 Dec 30

PMID 20038211

Citations 82

Authors

Peter J Amos

Sahil K Kapur

Peter C Stapor

Hulan Shang

Stefan Bekiranov

Moshe Khurgel

George T Rodeheaver

Shayn M Peirce

Adam J Katz

Affiliations

Soon will be listed here.

Abstract

Human adipose-derived stromal cells (ASCs) have been shown to possess therapeutic potential in a variety of settings, including cutaneous wound healing; however, it is unknown whether the regenerative properties of this cell type can be applied to diabetic ulcers. ASCs collected from elective surgical procedures were used to treat full-thickness dermal wounds in leptin receptor-deficient (db/db) mice. Cells were delivered either as multicellular aggregates or as cell suspensions to determine the impact of cell formulation and delivery methods on biological activity and in vivo therapeutic effect. After treatment with ASCs that were formulated as multicellular aggregates, diabetic wounds experienced a significant increase in the rate of wound closure compared to wounds treated with an equal number of ASCs delivered in suspension. Analysis of culture supernatant and gene arrays indicated that ASCs formulated as three-dimensional aggregates produce significantly more extracellular matrix proteins (e.g., tenascin C, collagen VI alpha3, and fibronectin) and secreted soluble factors (e.g., hepatocyte growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-14) compared to monolayer culture. From these results, it is clear that cell culture, formulation, and delivery method have a large impact on the in vitro and in vivo biology of ASCs.

Citing Articles

Stromal vascular fraction: Mechanisms and application in reproductive disorders.

Liu Z, Xie Q, Huang J World J Stem Cells. 2025; 17(1):101097.

PMID: 39866896 PMC: 11752457. DOI: 10.4252/wjsc.v17.i1.101097.

The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.

Da Silva K, Kumar P, Choonara Y Wound Repair Regen. 2025; 33(1):e13251.

PMID: 39780313 PMC: 11711308. DOI: 10.1111/wrr.13251.

Scaffold-free 3D culture systems for stem cell-based tissue regeneration.

Liu K, Chen Y, Hsieh C, Wang M, Zhong M, Cheng N APL Bioeng. 2024; 8(4):041501.

PMID: 39364211 PMC: 11446583. DOI: 10.1063/5.0225807.

Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example.

Hisamatsu D, Ikeba A, Yamato T, Mabuchi Y, Watanabe M, Akazawa C Inflamm Regen. 2024; 44(1):37.

PMID: 39152520 PMC: 11328379. DOI: 10.1186/s41232-024-00350-5.

Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications.

Shi Y, Yang X, Min J, Kong W, Hu X, Zhang J Front Endocrinol (Lausanne). 2024; 15:1343255.

PMID: 38681772 PMC: 11045945. DOI: 10.3389/fendo.2024.1343255.

References

Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao R . Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005; 332(2):370-9. DOI: 10.1016/j.bbrc.2005.04.135. View

Abbott C, Carrington A, ASHE H, Bath S, Every L, Griffiths J . The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002; 19(5):377-84. DOI: 10.1046/j.1464-5491.2002.00698.x. View

Sullivan S, Underwood R, Sigle R, Fukano Y, Muffley L, Usui M . Topical application of laminin-332 to diabetic mouse wounds. J Dermatol Sci. 2007; 48(3):177-88. PMC: 2151474. DOI: 10.1016/j.jdermsci.2007.07.002. View

Mitchell J, McIntosh K, Zvonic S, Garrett S, Floyd Z, Kloster A . Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2005; 24(2):376-85. DOI: 10.1634/stemcells.2005-0234. View

Rahman S, Patel Y, Murray J, Patel K, Sumathipala R, Sobel M . Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol. 2005; 6(1):8. PMC: 553973. DOI: 10.1186/1471-2121-6-8. View

Barber C, Watt A, Pham C, Humphreys K, Penington A, Mutimer K . Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. J Wound Care. 2008; 17(12):517-27. DOI: 10.12968/jowc.2008.17.12.31766. View

Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H . Survival of Apligraf in acute human wounds. Tissue Eng. 2004; 10(7-8):1180-95. DOI: 10.1089/ten.2004.10.1180. View

Pecoraro R, Reiber G, BURGESS E . Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990; 13(5):513-21. DOI: 10.2337/diacare.13.5.513. View

Katz A, Tholpady A, Tholpady S, Shang H, Ogle R . Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells. 2005; 23(3):412-23. DOI: 10.1634/stemcells.2004-0021. View

10.

Parker A, Katz A . Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther. 2006; 6(6):567-78. DOI: 10.1517/14712598.6.6.567. View

11.

Brown R, Greenhalgh D . Mouse models to study wound closure and topical treatment of infected wounds in healing-impaired and normal healing hosts. Wound Repair Regen. 1997; 5(2):198-204. DOI: 10.1046/j.1524-475X.1997.50213.x. View

12.

Telgenhoff D, Shroot B . Cellular senescence mechanisms in chronic wound healing. Cell Death Differ. 2005; 12(7):695-8. DOI: 10.1038/sj.cdd.4401632. View

13.

Trousdale R, Jacobs S, Simhaee D, Wu J, Lustbader J . Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. J Surg Res. 2008; 151(1):100-7. DOI: 10.1016/j.jss.2008.01.023. View

14.

Planat-Benard V, Silvestre J, Cousin B, Andre M, Nibbelink M, Tamarat R . Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004; 109(5):656-63. DOI: 10.1161/01.CIR.0000114522.38265.61. View

15.

Michaels 5th J, Churgin S, Blechman K, Greives M, Aarabi S, Galiano R . db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen. 2007; 15(5):665-70. DOI: 10.1111/j.1524-475X.2007.00273.x. View

16.

Kim W, Park B, Sung J . The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther. 2009; 9(7):879-87. DOI: 10.1517/14712590903039684. View

17.

Yoshida S, Matsumoto K, Tomioka D, Bessho K, Itami S, Yoshikawa K . Recombinant hepatocyte growth factor accelerates cutaneous wound healing in a diabetic mouse model. Growth Factors. 2004; 22(2):111-9. DOI: 10.1080/08977190410001701005. View

18.

Tsuboi R, Shi C, Rifkin D, Ogawa H . A wound healing model using healing-impaired diabetic mice. J Dermatol. 1992; 19(11):673-5. DOI: 10.1111/j.1346-8138.1992.tb03757.x. View

19.

Fuchs E, Tumbar T, Guasch G . Socializing with the neighbors: stem cells and their niche. Cell. 2004; 116(6):769-78. DOI: 10.1016/s0092-8674(04)00255-7. View

20.

Parker A, Shang H, Khurgel M, Katz A . Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy. 2007; 9(7):637-46. DOI: 10.1080/14653240701508452. View